Clinical Trial Update: Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial sponsored by the National Cancer Institute is evaluating the anti-cancer drug Triapine in endometrial serous carcinoma, using biom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Serous Carcinoma

Drugs mentioned

• Triapine (Triapine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Endometrial Serous Adenocarcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING